Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis

Technology in Cancer Research and Treatment

Volumn 10, Issue 4, 2011, Pages 381-389

  Shan, H B ^a,b   Zhang, R ^a,b   Li, Y ^a,b   Xu, G L ^a,b   Luo, G Y ^a,b   Gao, X Y ^a,b   Yang, H L ^a,c  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Cancer Center   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Colorectal polyps; Immunohistochemistry; Insulin like growth factor 1 receptor (IGF 1R); Quantitative real time RT PCR

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN C RECEPTOR;

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOENDOSCOPY; CLINICAL ARTICLE; COLON POLYP; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MALIGNANT TRANSFORMATION; MORPHOLOGY; PRECANCER; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM POLYP; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VILLOUS ADENOMA;

EID: 80053238900     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500215     Document Type: Article

References (23)

1. Gupta, S. Colorectal polyps: the scope and management of the problem. Am J Med Sci 336, 407-417 (2008).
2. Jass, J. R., Young, J., Leggett, B. A. Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol 17, 17-26 (2002).
3. Ahlquist, D. A. Molecular detection of colorectal neoplasia. Gastroenterology 138, 2127-2139 (2010).
4. Philippou, A., Halapas, A., Maridaki, M., Koutsilieris, M. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J Musculoskelet Neuronal Interact 7, 208-218 (2007).
5. Blair, H. C., Sun, L., Kohanski, R. A. Balanced regulation of proliferation, growth, differentiation, and degradation in skeletal cells. Ann NY Acad Sci 1116, 165-173 (2007).
6. Ibrahim, Y. H., Yee, D. Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res 14, 261-269 (2004).
7. Hartog, H., Wesseling, J., Boezen, H. M., van der Graaf, W. T. The insulin-like growth factor 1 receptor in cancer: old focus, new future. Eur J Cancer 43, 1895-1904 (2007).
8. Wu, Y., Yakar, S., Zhao, L., Hennighausen, L., LeRoith, D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62, 1030-1035 (2002).
9. Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., Semenza, G. L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277, 38205-38211 (2002).
10. Weber, M. M., Fottner, C., Liu, S. B., Jung, M. C., Engelhardt, D., Baretton, G. B. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas, Cancer 95, 2086-2095 (2002).
11. Ouban, A., Muraca, P., Yeatman, T., Coppola, D. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum Pathol 34, 803-808 (2003).
12. Remacle-Bonnet, M. M., Garrouste, F. L., Heller, S., André, F., Marvaldi, J. L., Pommier, G. J. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Cancer Res 60, 2007-2017 (2000).
13. Natalishvili, N., Axelson, M., Girnita, L., Larsson, O., Vasilcanu, D. Aberrant intracellular IGF-1R beta-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic transformation. Exp Cell Res 315, 1458-1467 (2009).
14. Vrieling, A., Voskuil, D. W., Bosma, A., Majoor, D. M., van Doorn, J., Cats, A., Depla, A. C., Timmer, R., Witteman, B. J., Wesseling, J., Kampman, E., Van't, Veer L. J. Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels. Growth Horm IGF Res 19, 126-135 (2009).
15. Hakam, A., Yeatman, T. J., Lu, L., Mora, L., Marcet, G., Nicosia, S.V., Karl, R. C. Coppola D. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum Pathol 30, 1128-1133 (1999).
16. Nosho, K., Yamamoto, H., Taniguchi, H., Adachi, Y., Yoshida, Y., Arimura, Y., Endo, T., Hinoda, Y., Imai, K. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Clin Cancer Res 10, 7950-7957 (2004).
17. Chao, A., Thun, M. J., Connell, C. J. Meat consumption and risk of colorectal cancer. JAMA 293, 172-182 (2005).
18. Cooper, H. S. Pathologic issues in the treatment of endoscopically removed malignant colorectal polyps. J Natl Compr Canc Netw 5, 991-996 (2007).
19. Kudo, S., Hirota, S., Nakajima, T., Hosobe, S., Kusaka, H., Kobayashi, T., Himori, M., Yagyuu, A. Colorectal tumours and pit pattern. J Clin Pathol 47, 880-885 (1994).
20. Tung, S. Y., Wu, C. S., Su, M.Y. Magnifying colonoscopy in differentiating neoplastic from nonneoplastic colorectal lesions. Am J Gastroenterol 96, 2628-2632 (2001)
21. Hopfner, M., Sutter, A. P., Huether, A., Baradari, V., Scherubl, H. Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer. World J Gastroenterol 12, 5635-5643 (2006).
22. Michor, F., Iwasa, Y., Rajagopalan, H., Lengauer, C., Nowak, M. A. Linear model of colon cancer initiation. Cell Cycle 3, 358-362 (2004).
23. Sokolov K., Aaron J., Hsu B., Nida, D., Gillenwater, A., Follen, M., MacAulay, C., Adler-Storthz, K., Korgel, B., Descour, M., Pasqualini, R., Arap, W., Lam, W., Richards-Kortum, R. Optical systems for in vivo molecular imaging of cancer. Technol Cancer Res Treat. 2, 491-504 (2003).